Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling pathway
- 1 November 2009
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 389 (3) , 516-522
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular healthThe Journal of Nutritional Biochemistry, 2008
- Peroxisome proliferator activated receptor γ agonists suppress TNFα-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen speciesImmunology Letters, 2008
- Differential roles of PKCα and PKCɛ in controlling the gene expression of Nox4 in human endothelial cellsFree Radical Biology and Medicine, 2008
- Implication of cytosolic phospholipase A2 (cPLA2) in the regulation of human synoviocyte NADPH oxidase (Nox2) activityLife Sciences, 2007
- Group V secretory PLA2 regulates TLR2-dependent eicosanoid generation in mouse mast cells through amplification of ERK and cPLA2α activationBlood, 2007
- Pseudolipasin A Is a Specific Inhibitor for Phospholipase A 2 Activity of Pseudomonas aeruginosa Cytotoxin ExoUInfection and Immunity, 2007
- The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibitionProceedings of the National Academy of Sciences, 2006
- Inflammation and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Serum Levels of Type II Secretory Phospholipase A2 and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and WomenArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Regulatory Functions of Phospholipase A2Critical Reviews in Immunology, 1997